Dr. Buff Mair is the new CTS Medical Director and replaces Dr. German Leparc who retired at the beginning of 2018. Several of the CTS client forms specify list the Medical Director in the header and these forms will be updated on March 5, 2018. Check out the Communication page for a complete list of forms or by clicking the link below: Communications
As winter weather continues to move through parts of the US, we would like to remind you it may be n...
Reminder - Dr. Buff Mair is the new CTS Medical Director. Several of the CTS client forms specify li...
After a recent reevaluation of the Monolisa anti-HBs EIA package insert, the CTS QA/Scientific team ...
On December 9, 2019, the new CTS Laboratory Information System successfully implemented in Phoe...
On July 6, 2018 the FDA released an industry guidance document for transitioning from individual to ...
This is the first update to the original CTS communication distributed on July 6th. As previously co...